Clinical trials: GRIN-related Neurodevelopmental Disorder
GRIN-related Neurodevelopmental Disorder
Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder
The Phase 3 portion of Study RAD-GRIN-101 is a multinational, multicenter, randomized, double-blind, placebo-controlled trial followed by an open-label extension to evaluate the efficacy and safety of radiprodil in participants…
- Trial name
- NCT07224581
- Testing
- Radiprodil
- Where
- 34 sites in United States, Belgium and 8 more
- Volunteers
- 100 people
- Sponsor
- GRIN Therapeutics, Inc.